Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a few extra pounds on the hip or a suddenly pronounced jawline instantly becomes the subject of a headline.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial of its experimental drug CagriSema — a combination of semaglutide and a medicine called cagrilintide. People on CagriSema lost about 23% of their body weight in a 68-week study, outperforming both drugs when taken alone.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces the risk of major cardiovascular events, such as heart a

Anne-Marie Zanzal, 60, and her wife Tonda McKay, 62, have also experienced the more positive changes that weight-loss drugs can have on romantic relationships. They say they had reached the "fat and happy stage of life" but realized being overweight was affecting their energy levels.